Liao WY - Search Results

1

Atezolizumab, bevacizumab, pemetrexed and platinum for EGFR-mutant NSCLC patients after EGFR TKI failure: A phase II study with immune cell profile analysis.

Wu SG, Ho CC, Yang JC, Yu SH, Lin YF, Lin SC, Liao BC, Yang CY, Lin YT, Yu CJ, Chuang YT, Liao WY, Yap KY, Kou WS, Shih JY. Wu SG, et al. Among authors: liao wy. Clin Transl Med. 2025 Jan;15(1):e70149. doi: 10.1002/ctm2.70149. Clin Transl Med. 2025. PMID: 39715697 Free PMC article. Clinical Trial.

2

Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer.

Liao WY, Chen JH, Wu M, Shih JY, Chen KY, Ho CC, Yang JC, Yu CJ. Liao WY, et al. Clin Lung Cancer. 2013 Jul;14(4):418-24. doi: 10.1016/j.cllc.2012.10.003. Epub 2013 Jan 4. Clin Lung Cancer. 2013. PMID: 23291258

3

Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non-Small-cell Lung Cancer Patients.

Wu TH, Hsiue EH, Lee JH, Lin CC, Liao WY, Ho CC, Shih JY, Yu CJ, Yang JC. Wu TH, et al. Among authors: liao wy. Clin Lung Cancer. 2018 May;19(3):e361-e372. doi: 10.1016/j.cllc.2018.01.005. Epub 2018 Feb 1. Clin Lung Cancer. 2018. PMID: 29477365

4

Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum.

Liao WY, Ho CC, Tsai TH, Chen KY, Shih JY, Yu CJ. Liao WY, et al. Lung Cancer. 2018 Apr;118:90-96. doi: 10.1016/j.lungcan.2018.01.011. Epub 2018 Feb 3. Lung Cancer. 2018. PMID: 29572009

5

Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations.

Lin YT, Chen JS, Liao WY, Ho CC, Hsu CL, Yang CY, Chen KY, Lee JH, Lin ZZ, Shih JY, Yang JC, Yu CJ. Lin YT, et al. Among authors: liao wy. Int J Cancer. 2019 Jun 1;144(11):2887-2896. doi: 10.1002/ijc.32025. Epub 2019 Jan 5. Int J Cancer. 2019. PMID: 30485437

6

Monitoring of T790M in plasma ctDNA of advanced EGFR-mutant NSCLC patients on first- or second-generation tyrosine kinase inhibitors.

Huang CT, Lin CA, Su TJ, Yang CY, Tsai TH, Hsu CL, Liao WY, Chen KY, Ho CC, Yu CJ. Huang CT, et al. Among authors: liao wy. BMC Cancer. 2023 Mar 13;23(1):234. doi: 10.1186/s12885-023-10698-5. BMC Cancer. 2023. PMID: 36915101 Free PMC article.

7

Effects of Early Short-Course Corticosteroids on Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors.

Huang DD, Liao BC, Hsu WH, Yang CY, Lin YT, Wu SG, Tsai TH, Chen KY, Ho CC, Liao WY, Shih JY, Yu CJ, Yang JC, Cheng AL, Shen YC. Huang DD, et al. Among authors: liao wy, liao bc. Oncology. 2024;102(4):318-326. doi: 10.1159/000534350. Epub 2023 Sep 29. Oncology. 2024. PMID: 37778345 Free article.

8

Tissue or liquid rebiopsy? A prospective study for simultaneous tissue and liquid NGS after first-line EGFR inhibitor resistance in lung cancer.

Lin YT, Ho CC, Hsu WH, Liao WY, Yang CY, Yu CJ, Tsai TH, Yang JC, Wu SG, Hsu CL, Hsieh MS, Huang YL, Wu CL, Shih JY. Lin YT, et al. Among authors: liao wy. Cancer Med. 2024 Jan;13(1):e6870. doi: 10.1002/cam4.6870. Epub 2023 Dec 22. Cancer Med. 2024. PMID: 38140788 Free PMC article.

9

Comprehensive Genomic Analysis of Patients With Non-Small-Cell Lung Cancer Using Blood-Based Circulating Tumor DNA Assay: Findings From the BFAST Database of a Single Center in Taiwan.

Wang HY, Ho CC, Lin YT, Liao WY, Chen CY, Shih JY, Yu CJ. Wang HY, et al. Among authors: liao wy. JCO Precis Oncol. 2024 Jan;8:e2300314. doi: 10.1200/PO.23.00314. JCO Precis Oncol. 2024. PMID: 38190582 Free PMC article.

10

Real-world analysis of survival outcomes in advanced EGFR-mutant NSCLC patients treated with platinum-pemetrexed after EGFR-TKI treatment failure.

Yao ZH, Liao WY, Yang CY, Ho CC, Shih JY, Chen KY, Yang JC, Yu CJ. Yao ZH, et al. Among authors: liao wy. J Formos Med Assoc. 2024 Aug 15:S0929-6646(24)00385-1. doi: 10.1016/j.jfma.2024.08.017. Online ahead of print. J Formos Med Assoc. 2024. PMID: 39152072 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters